US EditionExperimental Gene Therapy Successfully Treats Huntington's Disease for the First Time
A clinical trial at University College London showed gene therapy slowed Huntington’s disease progression by 75% in 29 patients, offering a potential one-time treatment.
9 Articles
9 Articles
Chorea Huntington unstoppably disintegrates the brain. Now researchers have succeeded in slowing down the course of the dreaded disease.
Huntington’s disease treated for first time using gene therapy
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed. Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.
It is a gene therapy, the first to be tested with these patients, which is given with brain surgery that lasts between 12 and 18 hours. More information: Beyond the ALS: the other rare (and devastating) diseases that 'nobody' talks about in Spain
British researchers have managed for the first time to slow down the progression of Huntington's disease in a handful of patients, which is a rare glimmer of hope for those with this debilitating neurodegenerative disease.
A new gene therapy could extend the lives of patients with Huntington's disease by years or even decades, according to a study by British researchers.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
